Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brusko

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Diabetes|July 30, 2009
Mesenchymal stem cells: a potential border patrol for transplanted islets?Todd M Brusko
The Journal of School Health|March 1, 1985
Starting a peer counseling program in the high schoolG H Blain, M Brusko
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2009
Regulatory T cells directed to the site of the actionTodd M Brusko, Jeffrey A Bluestone
Clinical and Experimental Immunology|July 17, 2019
Islet-immune interactions in type 1 diabetes: the nexus of beta cell destructionL Peters, A Posgai, T M Brusko
Frontiers in Endocrinology|November 1, 2021
Editorial: Footprints of Immune Cells in the Type 1 Diabetic PancreasTodd M Brusko, Roberto Mallone, Teresa Rodriguez-Calvo
Current Diabetes Reports|July 31, 2012
Autologous regulatory T cells for the treatment of type 1 diabetesJames A Thompson, Daniel Perry, Todd M Brusko
Immunological Reviews|July 11, 2008
Human regulatory T cells: role in autoimmune disease and therapeutic opportunitiesTodd M Brusko, Amy L Putnam, Jeffrey A Bluestone
Science (New York, N.Y.)|July 30, 2021
Strategies for durable β cell replacement in type 1 diabetesTodd M Brusko, Holger A Russ, Cherie L Stabler
Current Opinion in Endocrinology, Diabetes, and Obesity|May 31, 2019
Pleiotropic roles of the insulin-like growth factor axis in type 1 diabetesMelanie R Shapiro, Mark A Atkinson, Todd M Brusko
Frontiers in Endocrinology|November 3, 2017
Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 DiabetesMark A Wallet, Katherine E Santostefano, Naohiro Terada, et al.
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Diabetes|July 30, 2009
Mesenchymal stem cells: a potential border patrol for transplanted islets?Todd M Brusko
The Journal of School Health|March 1, 1985
Starting a peer counseling program in the high schoolG H Blain, M Brusko
Proceedings of the National Academy of Sciences of the United States of America|December 4, 2009
Regulatory T cells directed to the site of the actionTodd M Brusko, Jeffrey A Bluestone
Clinical and Experimental Immunology|July 17, 2019
Islet-immune interactions in type 1 diabetes: the nexus of beta cell destructionL Peters, A Posgai, T M Brusko
Frontiers in Endocrinology|November 1, 2021
Editorial: Footprints of Immune Cells in the Type 1 Diabetic PancreasTodd M Brusko, Roberto Mallone, Teresa Rodriguez-Calvo
Current Diabetes Reports|July 31, 2012
Autologous regulatory T cells for the treatment of type 1 diabetesJames A Thompson, Daniel Perry, Todd M Brusko
Immunological Reviews|July 11, 2008
Human regulatory T cells: role in autoimmune disease and therapeutic opportunitiesTodd M Brusko, Amy L Putnam, Jeffrey A Bluestone
Science (New York, N.Y.)|July 30, 2021
Strategies for durable β cell replacement in type 1 diabetesTodd M Brusko, Holger A Russ, Cherie L Stabler
Current Opinion in Endocrinology, Diabetes, and Obesity|May 31, 2019
Pleiotropic roles of the insulin-like growth factor axis in type 1 diabetesMelanie R Shapiro, Mark A Atkinson, Todd M Brusko
Frontiers in Endocrinology|November 3, 2017
Isogenic Cellular Systems Model the Impact of Genetic Risk Variants in the Pathogenesis of Type 1 DiabetesMark A Wallet, Katherine E Santostefano, Naohiro Terada, et al.
Pageof 16